IRIS
BARILLARI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.465
EU - Europa 1.720
AS - Asia 943
SA - Sud America 8
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 29.147
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.455
SG - Singapore 592
DE - Germania 419
UA - Ucraina 391
IE - Irlanda 287
CN - Cina 266
IT - Italia 192
FR - Francia 91
GB - Regno Unito 90
PL - Polonia 89
RU - Federazione Russa 45
SE - Svezia 40
KR - Corea 33
FI - Finlandia 32
TW - Taiwan 19
JP - Giappone 13
BE - Belgio 12
CA - Canada 9
ES - Italia 8
HK - Hong Kong 7
BR - Brasile 5
NL - Olanda 5
AL - Albania 4
CZ - Repubblica Ceca 4
DK - Danimarca 3
EU - Europa 3
IN - India 3
AT - Austria 2
AU - Australia 2
BD - Bangladesh 2
EG - Egitto 2
GR - Grecia 2
ID - Indonesia 2
LV - Lettonia 2
TR - Turchia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
BO - Bolivia 1
CH - Svizzera 1
FK - Isole Falkland (Malvinas) 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
LK - Sri Lanka 1
MA - Marocco 1
RO - Romania 1
Totale 29.147
Salva come PNG Salva come JPEG
Città #
Wilmington 7.694
Woodbridge 7.441
Houston 6.806
Fairfield 628
Chandler 577
Singapore 539
Ann Arbor 393
Dearborn 318
Ashburn 276
Dublin 267
Seattle 225
Cambridge 211
Jacksonville 207
Medford 201
New York 153
Santa Clara 130
Beijing 108
Lawrence 94
Kraków 88
Menlo Park 70
Rome 70
Zhengzhou 67
San Diego 52
Boardman 26
Milan 20
Redwood City 20
Mülheim 19
Nanjing 16
Norwalk 15
Moscow 13
Verona 13
Brussels 12
Mountain View 12
Phoenix 10
Center 9
Nuremberg 9
Guangzhou 8
Kaohsiung 8
London 8
Shanghai 8
University Park 7
Frankfurt Am Main 6
Frankfurt am Main 6
Hefei 6
Los Angeles 6
Mcallen 6
San Francisco 6
San Mateo 6
Toronto 6
Wuhan 6
Ayn 5
Council Bluffs 5
Helsinki 5
Kunming 5
Redmond 5
Colorado Springs 4
Engelhard 4
Foggia 4
Halle 4
Indiana 4
Kissimmee 4
Palo Alto 4
Salt Lake City 4
Seoul 4
Baotou 3
Cedarhurst 3
Hounslow 3
Iconha 3
Lappeenranta 3
Magenta 3
Olomouc 3
Osaka 3
Prescot 3
Sacramento 3
Shenyang 3
Shenzhen 3
Tirana 3
Washington 3
Arona 2
Beachwood 2
Cairo 2
Cesano Maderno 2
Chengdu 2
Columbus 2
Durban 2
Farmington 2
Fremont 2
Fuzhou 2
Gaeta 2
Guilford 2
Hebei 2
Hong Kong 2
Jiaxing 2
Jinan 2
Kelowna 2
Kilburn 2
La Veta 2
Las Rozas de Madrid 2
Leipzig 2
Manchester 2
Totale 27.049
Salva come PNG Salva come JPEG
Nome #
Detection of high nerve growth factor serum levels in AIDS-related and -unrelated Kaposi's sarcoma patients 478
Correlation between pathological data and the RNA expression of p53 or p53-targeted genes in primary invasive ductal breast carcinomas: a preliminary study 452
HTLV-V: a new human retrovirus isolated in a Tac-negative T cell lymphoma/leukemia 448
Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity. 432
The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis 425
HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway 414
Human T-lymphotropic retrovirus infection in Italy 413
Fibroblast growth factor-2 and the HIV-1 Tat protein synergize in promoting Bcl-2 expression and preventing endothelial cell apoptosis: implications for the pathogenesis of AIDS-associated Kaposi’s sarcoma. 409
The HIV protease inhibitor indinavir down-regulates the expression of the pro-angiogenic MT1-MMP by human endothelial cells 407
The fibroblast growth factors. 398
Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: implications for atherogenesis 396
Pharmacological management of Kaposi’s sarcoma. 396
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation independent mechanism which requires binding of Tat to viral particles 395
Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing alpha5beta1 integrin expression and function 393
Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells 393
Spindle cells from Acquired Immune Deficiency Syndrome-associated Kaposi’s sarcoma lesions express telomerase activity directly relating to the RNA levels of fibroblast growth factor-2. 388
Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses 383
Antitumor effects of antiretroviral therapy 378
HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection 376
Entrance of the tat protein of HIV-1 into human uterine cervical carcinoma cells causes upregulation of HPV-E6 expression and a decrease in p53 protein levels 370
Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: implications for atherogenesis. 365
A tricistronic retroviral vector expressing natural antiangiogenic factors inhibits angiogenesis in vitro, but is not able to block tumor progression in vivo 364
Follow-up study of patients with cervical intraepithelial neoplasia grade 1 overexpressing p16ink4a. 363
Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS 363
HIV protease inhibitors as new treatment options for Kaposi's sarcoma 361
Treatment of Kaposi's sarcoma--an update 361
HTLV-I and HIV infection in drug addicts in Italy 358
Molecular mechanisms in the pathogenesis of AIDS-associated Kaposi's sarcoma 357
Angiogenic properties of human immunodeficiency virus type 1 Tat protein 355
Pathogenesis of AIDS-associated Kaposi's sarcoma 355
Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients 353
Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via proteasome-independent block of angiogenesis and matrix metalloproteinases. 352
Another mechanism involved in AIDS-KS progression. 347
Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth 346
null 345
Transcription of placenta growth factor type-2 correlates with intratumoral microvessel density in breast carcinomas. 340
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation 335
The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence 335
HTLV-I is endemic in southern Italy: detection of the first infectious cluster in a white population 333
The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines 331
Human T-lymphotropic retroviruses: a new member of the family. 330
HIV protease inhibitors block angiogenesis and promote regression of Kaposi’s sarcoma in the nude mouse model. 329
Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir 327
Tat, the transactivator gene of HIV-1, activates the expression of tumor necrosis factor-beta. 323
Spindle cells from AIDS-associated Kaposi's sarcoma (KS) lesions express telomerase activity that is enhanced by KS progression factors. 321
The use of HAART for biological tumour therapy 315
Release-uptake of HIV-1 Tat and mechanisms of Tat-induced paracrine biological effects (TAT domains and pathways for cell growth and transactivation activity). 313
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation independent mechanism which requires binding of Tat to viral particles. 312
Release and angiogenic properties of extracellular HIV-1 Tat protein. 312
Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma 309
Immune activation, rather than immune deficiency, cooperates with HIV infection in the development of AIDS-associated Kaposi’s sarcoma. 309
Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor 309
Basic fibroblast growth factor mediates the growth and angiogenic activity of AIDS-Kaposi’s sarcoma (KS)-derived spindle cells and synergises with HIV-1 Tat protein in inducing KS-like lesions in mice. 308
Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma 301
IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis 301
Lymphokines released by activated or HTLV-infected T cells induce growth of normal mesenchymal cells and of cells derived from Kaposi’s sarcoma lesions of AIDS patients. 298
Basic fibroblast growth factor modifies the interactions between endothelial cells/fibronectin: Implications for progression of AIDS- associated Kaposi's sarcoma 296
HIV-1 Tat protein mimics the effect of extracellular matrix (ECM) protein on vascular cell growth and angiogenesis: implications for AIDS-Kaposi’s sarcoma (AIDS-KS) pathogenesis. 295
Interactions between endothelial cells and HIV-1 294
Tissue CEA as prognostic indicator in a series of 31 cases of gastric cancer 294
Role of HIV-1 TAT gene product and of cytokines released by activated immune cells in the pathogenesis of AIDS-associated Kaposi’s sarcoma. 292
Biological properties of Human Immunodeficiency Virus type-1 Tat protein: angiogenic effects and adhesive interactions of extracellular Tat. 291
The formation of new blood vessels in Kaposi’s sarcoma. 288
Integrin-mediated uptake of HIV-1 Tat protein by cytokine-activated endothelial cells. 288
Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin 288
PDGF-B as a possible growth factor in AIDS-KS. 288
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma 286
Mechanism of paclitaxel activity in Kaposi's sarcoma 284
HIV protease inhibitors: antiretroviral agents with anti-inflammatory, anti-angiogenic and anti-tumour activity 283
[Chronic T-lymphocyte lymphatic leukemia. Clinico-pathologic assessment and new epidemiologic data related to cases correlated with HTLV-I in Italy] 280
Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis 279
Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines 278
Biology of Kaposi's sarcoma 276
Multicistronic antiangiogenic retroviral vectors for the gene therapy of malignant brain tumors. 274
The angiogenic properties of HIV-I Tat protein are mediated by two different domains. 268
Release-uptake of HIV-1 Tat and mechanisms of Tat-induced paracrine biological effects. 268
T-helper phenotype chronic lymphocytic leukaemia and "adult T-cell leukaemia" in Italy. Endemic HTLV-I-related T-cell leukaemias in southern Europe 267
Role of cytokines from activated T cells and HIV-1 Tat protein in the pathogenesis of AIDS-associated Kaposi’s sarcoma. 267
Cytokines released by activated primary T cells stimulate the growth of AIDS-KS-derived cells and other cells of mesenchymal derivation. 265
Basic FGF induces lesions in mice resembling KS, and antisense oligonucleotides against this cytokine inhibit the growth and angiogenic activity of KS spindle cells. 263
HIV-1 Tat protein enhances angiogenesis and Kaposi’s sarcoma development triggered by inflammatory cytokines or bFGF by engaging the avb3 integrin. 259
The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor 254
Immune stimulation and HIV-1 infection have complementary effects in the induction and progression of AIDS-associated Kaposi’s sarcoma via release of cytokines and Tat. 251
Cooperation of HIV-1 Tat protein, inflammatory cytokines or bFGF in the pathogenesis of AIDS-Kaposis’s sarcoma. 249
[HIV protease inhibitors for the treatment of Kaposi's sarcoma] 248
Inflammatory cytokines increase mesenchymal cell growth and attachment induced by HIV-1 Tat protein and adhesion molecules: implications for AIDS-Kaposi’s sarcoma pathogenesis. 236
Activated peripheral blood lymphocytes produce factors promoting the growth of spindle cells derived from AIDS-associated Kaposi’s sarcoma. 210
Correlation between pathological data and the RNA expression of p53 or p53-targeted genes in primary invasive ductal breast carcinomas: a preliminary study 60
Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells 55
Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo 53
The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs 52
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction 51
HIV-1 tat protein enters dysfunctional endothelial cells via integrins and renders them permissive to virus replication 47
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 42
The impact of human papilloma viruses, matrix metallo-proteinases and HIV protease inhibitors on the onset and progression of uterine cervix epithelial tumors: A review of preclinical and clinical studies 41
Radioresistance in rhabdomyosarcomas: much more than a question of dose 40
Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo 36
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies 31
The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process 31
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation 28
Totale 29.206
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.210
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.652 0 0 676 725 765 913 662 620 618 704 509 460
2020/20214.376 485 462 553 554 471 576 523 341 109 75 200 27
2021/2022933 20 135 13 65 19 43 48 120 32 54 85 299
2022/20231.329 160 110 100 143 97 277 114 80 123 43 68 14
2023/2024462 49 13 23 17 38 161 21 12 10 38 17 63
2024/20251.074 91 680 303 0 0 0 0 0 0 0 0 0
Totale 29.461